Corporate news

28.02.2025
Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals
31.01.2025
Marinomed Biotech AG: Changes to the Management Board
20.01.2025
Marinomed Biotech AG: Restructuring proceedings successfully completed
19.12.2024
Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division
Lucia Ziegler, MSc
Head of Investor & Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com